Exodus Point Capital Management, LP Kaleido Biosciences, Inc. Transaction History

Exodus Point Capital Management, LP

  • $16.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$5.82 - $8.72 $73,733 - $110,473
-12,669 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$7.2 - $16.82 $91,216 - $213,092
12,669 New
12,669 $103,000
Q3 2020

Nov 16, 2020
SELL
$5.09 - $11.07 $51,083 - $111,098
-10,036 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$4.62 - $8.01 $46,366 - $80,388
10,036 New
10,036 $75,000

Others Institutions Holding KLDO

# of Institutions
2
Shares Held
2.65K
Call Options Held
0
Put Options Held
0
View Full List

About Kaleido Biosciences, Inc.

KLDO Quotes by TradingView
  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email